Form 4: Aurinia Pharmaceuticals Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David R.W. Jayne, a director of Aurinia Pharmaceuticals, sold 4,946 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On May 21, 2024, David R.W. Jayne, a director of Aurinia Pharmaceuticals Inc., sold 4,946 shares of common stock.
- The sale was executed at a price of $5.74 per share.
- This transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on May 19, 2023.
- Following the transaction, Jayne directly owns 44,364 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and officers.
Key Dates
| Date | Description |
|---|---|
| 05/19/2023 | Date of grant for Restricted Stock Units |
| 05/21/2024 | Date of transaction (sale of shares) |
| 05/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.